About The Herbert Irving Comprehensive Cancer Center

The Herbert Irving Comprehensive Cancer Center (HICCC) is the home for cancer research and patient care at Columbia University and NewYork-Presbyterian/Columbia University Irving Medical Center. Our cancer center researchers and physicians are dedicated to understanding the complex biology behind cancer, from before it begins to its evolution and spread. We apply that knowledge to the discovery and design of innovative cancer therapies and prevention strategies that reduce the disease’s incidence and progression and improve the quality of life for all those affected - in our region and throughout the world.

The HICCC is one of only 51 National Cancer Institute (NCI)-designated comprehensive cancer centers in the United States, a designation that we have maintained since 1979. The HICCC has more than 200 members across six schools at Columbia University with more than $20 million in National Cancer Institute funding and nearly $100 million in cancer grants.

Partnering with the top hospital and leading academic center in New York City, NewYork-Presbyterian Hospital and Columbia University, the HICCC fosters a community of scientific excellence and outstanding patient care.